Lausanne, Switzerland · Founded 2023 · Privately Held (backing)
Developer of next-generation CAR-T cell therapies designed to cure solid tumours, specifically targeting aggressive brain cancers. Cellula Therapeutics is based in Lausanne, Switzerland and was founded in 2023. Its last reported valuation was $13.9 million in Jul 2025. It has raised $3.6 million.
Last reported valuation
$13.9M
Oct 2026
Priced at
—
Total raised
$3.6M
Last round
—
Cap table — not yet on record
Cellula Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Cellula Therapeutics with a free Private Market View account
·Watch Cellula Therapeutics: the Monday email on marks, rounds and moves
